Cited In for PMID: 23479179

Year	Number of Results
2013	2
2014	4
2015	5
2016	6
2017	2
2018	1
2019	2
2020	2
2021	1
2022	4
2023	1
2024	1

1

IL-32 expression is an independent prognostic marker for gastric cancer.

Ishigami S, Arigami T, Uchikado Y, Setoyama T, Kita Y, Sasaki K, Okumura H, Kurahara H, Kijima Y, Harada A, Ueno S, Natsugoe S. Ishigami S, et al. Med Oncol. 2013 Jun;30(2):472. doi: 10.1007/s12032-013-0472-4. Epub 2013 Mar 12. Med Oncol. 2013. PMID: 23479179

2

Role of interleukin‑32 in cancer progression (Review).

Meng D, Dong H, Wang C, Zang R, Wang J. Meng D, et al. Oncol Lett. 2023 Dec 12;27(2):54. doi: 10.3892/ol.2023.14187. eCollection 2024 Feb. Oncol Lett. 2023. PMID: 38192653 Free PMC article. Review.

3

Clinical implications of interleukins-31, 32, and 33 in gastric cancer.

Liu QH, Zhang JW, Xia L, Wise SG, Hambly BD, Tao K, Bao SS. Liu QH, et al. World J Gastrointest Oncol. 2022 Sep 15;14(9):1808-1822. doi: 10.4251/wjgo.v14.i9.1808. World J Gastrointest Oncol. 2022. PMID: 36187404 Free PMC article.

4

Inflammation and Gastric Cancer.

Jaroenlapnopparat A, Bhatia K, Coban S. Jaroenlapnopparat A, et al. Diseases. 2022 Jun 22;10(3):35. doi: 10.3390/diseases10030035. Diseases. 2022. PMID: 35892729 Free PMC article. Review.

5

A Paradoxical Effect of Interleukin-32 Isoforms on Cancer.

Shim S, Lee S, Hisham Y, Kim S, Nguyen TT, Taitt AS, Hwang J, Jhun H, Park HY, Lee Y, Yeom SC, Kim SY, Kim YG, Kim S. Shim S, et al. Front Immunol. 2022 Feb 25;13:837590. doi: 10.3389/fimmu.2022.837590. eCollection 2022. Front Immunol. 2022. PMID: 35281008 Free PMC article. Review.

6

Identification of molecular subtyping system and four-gene prognostic signature with immune-related genes for uveal melanoma.

Xia F, Yu Z, Deng A, Gao G. Xia F, et al. Exp Biol Med (Maywood). 2022 Feb;247(3):246-262. doi: 10.1177/15353702211053801. Epub 2021 Nov 7. Exp Biol Med (Maywood). 2022. PMID: 34743576 Free PMC article.

7

Associations between Interleukin-32 Gene Polymorphisms rs12934561 and rs28372698 and Susceptibilities to Bladder Cancer and the Prognosis in Chinese Han Population.

Yang J, Jian Z, Shen P, Bai Y, Tang Y, Wang J. Yang J, et al. Dis Markers. 2020 Nov 5;2020:8860445. doi: 10.1155/2020/8860445. eCollection 2020. Dis Markers. 2020. PMID: 33204366 Free PMC article.

8

Local and Systemic Interleukin-32 in Esophageal, Gastric, and Colorectal Cancers: Clinical and Diagnostic Significance.

Diakowska D, Krzystek-Korpacka M. Diakowska D, et al. Diagnostics (Basel). 2020 Oct 4;10(10):785. doi: 10.3390/diagnostics10100785. Diagnostics (Basel). 2020. PMID: 33020452 Free PMC article.

9

IL-32 expression indicates unfavorable prognosis in patients with colon cancer.

Zhai JM, An YH, Wang W, Fan YG, Yao GL. Zhai JM, et al. Oncol Lett. 2019 May;17(5):4655-4660. doi: 10.3892/ol.2019.10136. Epub 2019 Mar 12. Oncol Lett. 2019. PMID: 30988822 Free PMC article.

10

Interleukin-32: Frenemy in cancer?

Han S, Yang Y. Han S, et al. BMB Rep. 2019 Mar;52(3):165-174. doi: 10.5483/BMBRep.2019.52.3.019. BMB Rep. 2019. PMID: 30638183 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

26 results

Results by year